Indinavir Plus Efavirenz Plus Adefovir Dipivoxil in HIV-Infected Patients Who Have Not Had Success With Nelfinavir

PHASE3CompletedINTERVENTIONAL
Enrollment

120

Participants

Timeline

Start Date

Not specified

Conditions
HIV Infections
Interventions
DRUG

Indinavir sulfate

DRUG

Efavirenz

DRUG

Levocarnitine

DRUG

Adefovir dipivoxil

Trial Locations (11)

10032

Columbia Presbyterian Hosp, New York

19899

Med Ctr of Delaware, Wilmington

37212

Vanderbilt Clinic, Nashville

75219

Oaklawn Physicians Group, Dallas

90033

LAC / USC Med Ctr / Infectious Diseases, Los Angeles

96816

Hawaii AIDS Clinical Trial Unit, Honolulu

117948153

AIDS TMT Unit / Univ Hosp, Stony Brook

212876220

Johns Hopkins Hosp, Baltimore

606123832

Rush Presbyterian Saint Lukes Med Ctr, Chicago

06510

Yale Univ / AIDS Clinical Trials Unit, New Haven

02114

Massachusetts Gen Hosp, Boston

All Listed Sponsors
lead

Merck Sharp & Dohme LLC

INDUSTRY

NCT00002220 - Indinavir Plus Efavirenz Plus Adefovir Dipivoxil in HIV-Infected Patients Who Have Not Had Success With Nelfinavir | Biotech Hunter | Biotech Hunter